Jan 24, 2019 12:15:00 AM

PromarkerD US market update

Proteomics International rescinds PromarkerD exclusive licence deal with PrismHealthDx in US – negotiations brought forward with new tier 1 partners.

2019

Dr Richard Lipscombe, Managing Director of Proteomics International, spoke with ABN Newswire...

Proteomics International has been granted a new patent that has important longer-term potential...

Preliminary results show several plasma proteins are statistically significant biomarkers for...

Related posts